RegeneRx Biopharmaceuticals, Inc. (RGRX) Completes Patient Enrollment of First Phase II Clinical Trial
8/20/2008
More...
|
Diamyd Medical AB’s Licensee Reports Progress with GAD in Parkinson
8/20/2008
More...
|
Advanced Cell Technology Release: Clinical-Scale Generation of Functional Red Blood Cells from Human Embryonic Stem Cells
8/20/2008
More...
|
Lorus Therapeutics Inc. (LRP) Announces the Identification of a Potential Novel Biomarker in Patient Samples From a Clinical Trial of LOR-2040 Combined With Capecitabine in Breast Cancer
8/20/2008
More...
|
Elanco Announces Acquisition of Posilac(R) Dairy Business Deal Provides Strategic Fit with Eli Lilly and Company (LLY)'s Animal Health Division
8/20/2008
More...
|
JHP Pharmaceuticals and SpePharm Complete Purchase of Dantrium(R)
8/20/2008
More...
|
West Pharmaceutical Services Adopts BoardVantage
8/20/2008
More...
|
Bristol-Myers Squibb Company (BMY) and PDL BioPharma, Inc. (PDLI) Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma
8/20/2008
More...
|
Stanford University, German Institute in Research Alliance
8/20/2008
More...
|
Rosetta Genomics Ltd. (ROSG) and the National Institutes of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
8/20/2008
More...
|
HST Global, Inc. (HSTC) Announces Strategic Alliance with EBITDA Capital
8/20/2008
More...
|
MediGene, Inc. Release: European Patent Granted on the Application of Anti-L1 Antibodies in Cancer Therapy
8/20/2008
More...
|
Lpath, Inc. Receives $6.4 Million Equity Financing
8/20/2008
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Announces Reverse Stock Split
8/20/2008
More...
|
PDL BioPharma, Inc. (PDLI) Announces Investor Conference Call Today
8/20/2008
More...
|
Particle Sciences Expands Its Combination Product Capabilities
8/20/2008
More...
|
Sigma-Aldrich Corporation (SIAL) and Atlas Antibodies Announce the Release of 2,000 New, Highly-Validated Prestige Antibodies
8/20/2008
More...
|
|
SinoBiomed Inc. (SOBM) Release: Progress on Clinical Trials and Highly Successful Application of Patented Biotechnology Into Consumer Product Line
|